Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Dec-23 5:37 PM View:  | Point Biopharma Global Inc. (RACA) | 27-Dec-23 | Disposition | 3,600 | -- | -- | (100%) 3.6K to 0 | |
| 27-Dec-23 5:37 PM View: | Point Biopharma Global Inc. (RACA) | 26-Dec-23 | Disposition (change in control) | 35,400 | -- | -- | (91%) 39.0K to 3.6K | |
| 28-Nov-22 4:03 PM View: | Point Biopharma Global Inc. (RACA) | 23-Nov-22 | Private Purchase | 3,600 | $6.85 | $24,660.00 | 100% 0 to 3.6K | |
| 09-Feb-22 5:52 PM View: | Arcellx, Inc. (ACLX) | 08-Feb-22 | Conversion | 21,659 | -- | -- | 100% 0 to 21.66K | |
| 23-Sep-20 7:10 PM View: | Dyne Therapeutics, Inc. (DYN) | 21-Sep-20 | Conversion | 53,625 | -- | -- | 100% 0 to 53.63K | |
| 03-Apr-20 9:02 AM View: | Ra Pharmaceuticals, Inc. (RARX) | 02-Apr-20 | Disposition | 15,622 | $48.00 | $749,856.00 | (100%) 15.62K to 0 | |
| 07-Jun-19 4:36 PM View: | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition | 29,124 | $25.50 | $742,662.00 | (100%) 29.12K to 0 | < 1% |
| 05-Feb-19 7:39 PM View: | Ra Pharmaceuticals, Inc. (RARX) | 01-Feb-19 | Payment of Exercise | 3,291 | $21.00 | $69,111.00 | (32%) 10.42K to 7.13K | 5% |
| 05-Feb-19 7:39 PM View: | Ra Pharmaceuticals, Inc. (RARX) | 01-Feb-19 | Option Exercise | 10,417 | -- | -- | 100% 0 to 10.42K | |
| 17-Aug-15 5:03 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 14-Aug-15 | Option Exercise | 9,500 | $7.94 | $75,430.00 | 14% 69.27K to 78.77K | |
| 17-Aug-15 5:03 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 14-Aug-15 | Market Option Sale (Planned) | 9,500 | $42.92 | $407,740.00 | (12%) 78.77K to 69.27K | 98% |
| 15-Jul-15 6:30 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 14-Jul-15 | Option Exercise | 7,500 | $3.37 | $25,277.90 | 11% 69.27K to 76.77K | |
| 15-Jul-15 6:30 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 14-Jul-15 | Market Option Sale (Planned) | 7,500 | $48.92 | $366,900.00 | (10%) 76.77K to 69.27K | 98% |
| 16-Jun-15 5:11 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 15-Jun-15 | Option Exercise | 7,500 | $2.03 | $15,225.00 | 11% 69.27K to 76.77K | |
| 16-Jun-15 5:11 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 15-Jun-15 | Market Sale (Planned) | 7,500 | $41.67 | $312,525.00 | (10%) 76.77K to 69.27K | 98% |
| 16-Jun-15 5:11 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 12-Jun-15 | Market Option Sale | 7,500 | $41.29 | $309,675.00 | (9%) 79.27K to 71.77K | 98% |
| 16-Jun-15 5:11 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 12-Jun-15 | Market Sale | 2,500 | $41.29 | $103,225.00 | (3%) 71.77K to 69.27K | 98% |
| 18-May-15 5:00 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 14-May-15 | Option Exercise | 15,000 | $2.03 | $30,450.00 | 19% 79.27K to 94.27K | |
| 18-May-15 5:00 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 14-May-15 | Market Option Sale (Planned) | 15,000 | $39.28 | $589,200.00 | (16%) 94.27K to 79.27K | 97% |
| 18-Jun-14 4:39 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 17-Jun-14 | Market Sale (Planned) | 13,530 | $12.51 | $169,260.00 | (15%) 91.99K to 78.46K | 92% |
| 10-Mar-14 4:08 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 06-Mar-14 | Market Sale (Planned) | 4,510 | $13.65 | $61,561.50 | (5%) 96.5K to 91.99K | 93% |
| 13-Feb-14 5:20 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 12-Feb-14 | Market Sale (Planned) | 4,506 | $13.92 | $62,723.50 | (4%) 101.01K to 96.5K | 93% |
| 11-Feb-14 4:12 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 07-Feb-14 | Option Exercise | 88,391 | $1.58 | $139,435.00 | 392% 22.55K to 110.94K | |
| 11-Feb-14 4:12 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 07-Feb-14 | Market Option Sale | 9,928 | $14.22 | $141,176.00 | (9%) 110.94K to 101.01K | 93% |
| 27-Mar-13 8:04 PM View: | Tetraphase Pharmaceuticals,... (TTPH) | 25-Mar-13 | Conversion | 10,297 | -- | -- | 84% 12.25K to 22.55K |